Sfj Pharmaceuticals, Inc.

Sfj Pharmaceuticals, Inc. company information, Employees & Contact Information

The SFJ Pharmaceuticals Group is a Specialty Pharma Company deploying a new business model for the clinical development and registration of pharmaceutical products. Established in 2009, SFJ provides a financially advantageous and creative alternative approach to partnering. SFJ can provide the strategic financing, clinical development and regulatory resources for the clinical development and approval or your products. SFJ is staffed with a seasoned team of professionals, with extensive experience in the clinical development and regulatory approval of pharmaceutical products on a global basis. SFJ has offices in the United States, Europe, Japan, Singapore, Caymans, and Korea.

Company Details

Employees
28
Founded
-
Address
5000 Hopyard Road,
Phone
925-249-1234
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Keywords
Aventura.
HQ
Pleasanton, CA
Looking for a particular Sfj Pharmaceuticals, Inc. employee's phone or email?

Sfj Pharmaceuticals, Inc. Questions

News

REVERSE-IT: Bentracimab Effective in Reversing Ticagrelor Antiplatelet Effects - HCPLive

REVERSE-IT: Bentracimab Effective in Reversing Ticagrelor Antiplatelet Effects HCPLive

FDA accepts SFJ and SERB's bentracimab BLA for priority review - Pharmaceutical Technology

FDA accepts SFJ and SERB's bentracimab BLA for priority review Pharmaceutical Technology

Carlyle-backed life sciences investor launches $1.5bn clinical trials fund - Financial Times

Carlyle-backed life sciences investor launches $1.5bn clinical trials fund Financial Times

Serb Pharmaceutical Acquires Rights to SFJ’s Bentracimab - Contract Pharma

Serb Pharmaceutical Acquires Rights to SFJ’s Bentracimab Contract Pharma

Goldilocks and the 'not great, but good enough': Drug development shops offer 'sweet spot' deal alternative - Fierce Biotech

Goldilocks and the 'not great, but good enough': Drug development shops offer 'sweet spot' deal alternative Fierce Biotech

SFJ Pharmaceuticals Announces Closing of Transfer of Bentracimab Assets from PhaseBio Pharmaceuticals - Business Wire

SFJ Pharmaceuticals Announces Closing of Transfer of Bentracimab Assets from PhaseBio Pharmaceuticals Business Wire

Mintz Advises Sixth Street in a Non-Dilutive, Senior Secured Credit Facility of up to $475 Million for Apellis Pharmaceuticals - Mintz

Mintz Advises Sixth Street in a Non-Dilutive, Senior Secured Credit Facility of up to $475 Million for Apellis Pharmaceuticals Mintz

SERB Pharmaceuticals buys US rights for bentracimab from SFJ - Pharmaceutical Technology

SERB Pharmaceuticals buys US rights for bentracimab from SFJ Pharmaceutical Technology

Apellis Pharmaceuticals Refinances Existing Debt with Up to $475 Million Non-Dilutive Credit Facility from Sixth Street - Sixth Street

Apellis Pharmaceuticals Refinances Existing Debt with Up to $475 Million Non-Dilutive Credit Facility from Sixth Street Sixth Street

Apellis Pharmaceuticals Refinances Existing Debt with Up to $475 Million Non-Dilutive Credit Facility from Sixth Street - WilmerHale

Apellis Pharmaceuticals Refinances Existing Debt with Up to $475 Million Non-Dilutive Credit Facility from Sixth Street WilmerHale

Merck KGaA, Darmstadt, Germany to Develop Abituzumab in Metastatic Colorectal Cancer with SFJ Pharmaceuticals Group - PR Newswire

Merck KGaA, Darmstadt, Germany to Develop Abituzumab in Metastatic Colorectal Cancer with SFJ Pharmaceuticals Group PR Newswire

PhaseBio Files for Bankruptcy, Inks Deal to Sell Assets to Unnamed Company (Updated) - BioSpace

PhaseBio Files for Bankruptcy, Inks Deal to Sell Assets to Unnamed Company (Updated) BioSpace

Former White House Advisor: President Trump Could Unlock $150 Trillion in Untapped U.S. Resources - The Manila Times

Former White House Advisor: President Trump Could Unlock $150 Trillion in Untapped U.S. Resources The Manila Times

The Patient’s Perspective on Treatment with Dacomitinib: Patient-Reported Outcomes from the Phase III Trial ARCHER 1050 - Taylor & Francis Online

The Patient’s Perspective on Treatment with Dacomitinib: Patient-Reported Outcomes from the Phase III Trial ARCHER 1050 Taylor & Francis Online

PhaseBio Files for Bankruptcy Following Blackstone-Backed Partner’s Lawsuit - The Wall Street Journal

PhaseBio Files for Bankruptcy Following Blackstone-Backed Partner’s Lawsuit The Wall Street Journal

Serb Pharmaceuticals adding jobs in Montgomery County after securing licensing deal - The Business Journals

Serb Pharmaceuticals adding jobs in Montgomery County after securing licensing deal The Business Journals

SFJ Pharma, Pfizer collaborate for dacomitinib trial - BioSpectrum Asia

SFJ Pharma, Pfizer collaborate for dacomitinib trial BioSpectrum Asia

Antidote to ticagrelor reverses bleeding, restores platelet function - Healio

Antidote to ticagrelor reverses bleeding, restores platelet function Healio

Nektar stops clinical trials for key cancer drug, shares tumble - Reuters

Nektar stops clinical trials for key cancer drug, shares tumble Reuters

PhaseBio taps a manufacturing partner as it eyes 2022 filing for Brilinta-reversing drug - Fierce Biotech

PhaseBio taps a manufacturing partner as it eyes 2022 filing for Brilinta-reversing drug Fierce Biotech

Apellis Pharmaceuticals, Inc. SEC 10-Q Report - TradingView

Apellis Pharmaceuticals, Inc. SEC 10-Q Report TradingView

The golden triangle - - Global Venturing

The golden triangle - Global Venturing

Dr. Shelley Chu - Lightspeed Venture Partners

Dr. Shelley Chu Lightspeed Venture Partners

Bentracimab reverses ticagrelor's antiplatelet effects during surgery and bleeding events - News-Medical

Bentracimab reverses ticagrelor's antiplatelet effects during surgery and bleeding events News-Medical

EMPAVELI (pegcetacoplan) for the Treatment of Paroxysmal Nocturnal Haemoglobinuria (PNH) - Clinical Trials Arena

EMPAVELI (pegcetacoplan) for the Treatment of Paroxysmal Nocturnal Haemoglobinuria (PNH) Clinical Trials Arena

ACC 2025: 7 Trials to Watch - HCPLive

ACC 2025: 7 Trials to Watch HCPLive

Nektar to cut 500 jobs, sublease some Bay Area space after clinical trial failures - San Francisco Business Times - The Business Journals

Nektar to cut 500 jobs, sublease some Bay Area space after clinical trial failures - San Francisco Business Times The Business Journals

Second-Line Therapy With Adagrasib in KRAS G12C–Mutated Non–Small Cell Lung Cancer - The ASCO Post

Second-Line Therapy With Adagrasib in KRAS G12C–Mutated Non–Small Cell Lung Cancer The ASCO Post

Axitinib – Treatment for Advanced Renal Cell Carcinoma - Clinical Trials Arena

Axitinib – Treatment for Advanced Renal Cell Carcinoma Clinical Trials Arena

Silicon Valley Bank collapse could create 'very serious situation' for some Philadelphia life sciences companies - The Business Journals

Silicon Valley Bank collapse could create 'very serious situation' for some Philadelphia life sciences companies The Business Journals

Top Sfj Pharmaceuticals, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant